OraSure Technologies Inc. (OSUR) SVP Jack E. Jerrett Sells 24,000 Shares
OraSure Technologies Inc. (NASDAQ:OSUR) SVP Jack E. Jerrett sold 24,000 shares of the firm’s stock in a transaction dated Wednesday, November 23rd. The shares were sold at an average price of $9.00, for a total transaction of $216,000.00. Following the completion of the sale, the senior vice president now owns 60,105 shares of the company’s stock, valued at approximately $540,945. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Shares of OraSure Technologies Inc. (NASDAQ:OSUR) opened at 8.93 on Monday. The firm has a 50-day moving average of $7.90 and a 200 day moving average of $7.48. OraSure Technologies Inc. has a 1-year low of $5.09 and a 1-year high of $9.05. The stock has a market capitalization of $497.67 million, a PE ratio of 29.77 and a beta of 1.50.
OraSure Technologies (NASDAQ:OSUR) last posted its earnings results on Wednesday, November 2nd. The company reported $0.11 EPS for the quarter, topping the consensus estimate of $0.07 by $0.04. OraSure Technologies had a net margin of 13.70% and a return on equity of 10.27%. The firm earned $32.25 million during the quarter, compared to analysts’ expectations of $31.45 million. During the same quarter in the prior year, the firm earned $0.03 EPS. OraSure Technologies’s quarterly revenue was up 7.9% on a year-over-year basis. On average, equities analysts anticipate that OraSure Technologies Inc. will post $0.29 earnings per share for the current fiscal year.
A number of equities research analysts have recently issued reports on OSUR shares. TheStreet upgraded shares of OraSure Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, August 30th. BTIG Research downgraded shares of OraSure Technologies from a “buy” rating to a “neutral” rating and set a $8.00 price target for the company. in a research report on Monday, September 19th. Stephens upgraded shares of OraSure Technologies from an “equal weight” rating to an “overweight” rating in a research report on Monday, August 29th. Jefferies Group reiterated a “buy” rating and set a $10.00 price target (up from $8.00) on shares of OraSure Technologies in a research report on Wednesday, August 31st. Finally, Canaccord Genuity lifted their price target on shares of OraSure Technologies from $7.00 to $10.00 and gave the company a “buy” rating in a research report on Wednesday, August 24th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $8.58.
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Walleye Trading LLC boosted its position in OraSure Technologies by 61.9% in the second quarter. Walleye Trading LLC now owns 18,300 shares of the company’s stock valued at $108,000 after buying an additional 7,000 shares during the period. Stevens Capital Management LP raised its stake in shares of OraSure Technologies by 15.9% in the third quarter. Stevens Capital Management LP now owns 14,514 shares of the company’s stock worth $116,000 after buying an additional 1,995 shares in the last quarter. Springbok Capital Management LLC raised its stake in shares of OraSure Technologies by 126.7% in the first quarter. Springbok Capital Management LLC now owns 16,300 shares of the company’s stock worth $118,000 after buying an additional 9,110 shares in the last quarter. Janney Montgomery Scott LLC raised its stake in shares of OraSure Technologies by 3.2% in the second quarter. Janney Montgomery Scott LLC now owns 18,824 shares of the company’s stock worth $121,000 after buying an additional 579 shares in the last quarter. Finally, Eagle Global Advisors LLC bought a new stake in shares of OraSure Technologies during the third quarter worth $131,000. Hedge funds and other institutional investors own 81.91% of the company’s stock.
OraSure Technologies Company Profile
OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.
Receive News & Stock Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related stocks with our FREE daily email newsletter.